4.8 Letter

Lysosomal inhibition attenuates peroxisomal gene transcription via suppression of PPARA and PPARGC1A levels

Journal

AUTOPHAGY
Volume 15, Issue 8, Pages 1455-1459

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2019.1609847

Keywords

lipid oxidation; lysosomes; NAFLD; peroxisomes; steatohepatitis

Categories

Funding

  1. National Medical Research Council, Singapore [NMRC/CSA/0054/2013]
  2. Wellcome Trust/DBT India Alliance Fellowship [IA/I/16/2/502691]
  3. [NMRC/BNIG/2025/2014]

Ask authors/readers for more resources

Lysosomes influence dynamic cellular processes such as nutrient sensing and transcriptional regulation. To explore novel transcriptional pathways regulated by lysosomes, we performed microarray analysis followed by qPCR validation in a mouse hepatocyte cell line, AML12, treated with bafilomycin A(1) (lysosomal v-type H+-translocating ATPase inhibitor). Pathway enrichment analysis revealed significant downregulation of gene sets related to peroxisomal biogenesis and peroxisomal lipid oxidation upon lysosomal inhibition. Mechanistically, pharmacological inhibition of lysosomes as well as genetic knockdown of Tfeb led to downregulation of the peroxisomal master regulator PPARA and its coactivator PPARGC1A/PGC1 alpha. Consistently, ectopic induction of PPARA transcriptional activity rescues the effects of lysosomal inhibition on peroxisomal gene expression. Collectively, our results uncover a novel metabolic regulation of peroxisomes by lysosomes via PPARA-PPARGC1A transcriptional signalling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available